Clinical validation of host biomarker signature for distinguishing bacterial versus viral lower respiratory tract infections (LRTI) in adults at the point-of-need

Projektinformationen

Respiratory-ImmunoDx

ID Finanzhilfevereinbarung: 684589

DOI 10.3030/684589

Projekt abgeschlossen

EK-Unterschriftsdatum 27 November 2015

Startdatum 1 Dezember 2015

Enddatum 30 November 2018

Finanziert unter

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Gesamtkosten € 2 935 000,00

EU-Beitrag € 2 935 000,00

Koordiniert durch

MEMED DIAGNOSTICS LTD
Israel

Leistungen

Websites, patent fillings, videos etc. (2)

A dedicated website for OBSERVER and ImmunoDx™

D6.1 A dedicated website for OBSERVER and ImmunoDx™

Presenting at infectious disease conference

D6.2 Presenting OBSERVER study results in an infectious disease conference